Medicare Enrolled
Dr. Snehal Patel, M.D.
Nephrology · Middletown, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Snehal Patel is a nephrology specialist in Middletown, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 1,629 Medicare services across 902 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $1,512 from 18 pharmaceutical and/or device companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in OH
$1,512 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,629
Medicare services
Top 15% in OH for nephrology
902
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
387 | $59 | $140 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
358 | $66 | $260 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
236 | $88 | $200 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
137 | $258 | $578 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
92 | $128 | $325 |
| Hemodialysis circuit intervention with balloon dilation A procedure to insert a needle or tube into a hemodialysis circuit and dilate the dialysis segment using a balloon, with radiological review. |
72 | $161 | $701 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
57 | $10 | $37 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
43 | $225 | $462 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
32 | $52 | $191 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
30 | $96 | $225 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $109 | $340 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $56 | $184 |
| Needle or tube insertion into hemodialysis circuit with radiologist review A procedure involving the insertion of a needle or tube into a hemodialysis circuit, accompanied by a review of the procedure by a radiologist. |
18 | $97 | $493 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
17 | $13 | $44 |
| Removal of tunneled central venous tube This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein. |
16 | $92 | $400 |
| Contrast injection for X-ray imaging Administration of a contrast agent into a vein in the arm or leg to enhance visibility during an X-ray imaging procedure. |
14 | $33 | $161 |
| Arterial catheter insertion, first order branch Placement of a catheter into a primary branch of an artery in the chest or arm. |
13 | $94 | $621 |
| Replacement of tunneled central venous tube This procedure involves replacing an existing tunneled central venous catheter with a new one. The new tube is inserted through the same tunnel under the skin to maintain vascular access. |
13 | $111 | $533 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
13 | $61 | $203 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $87 | $300 |
| Pre-operative ultrasound for hemodialysis access A complete ultrasound assessment of artery and vein blood flow performed before surgery to evaluate hemodialysis access. |
12 | $16 | $61 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
20.1% medium
78.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,512
Total received (2018-2024)
Avg $216/year across 7 years
Top 39% in OH for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
72
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,512 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$591
2023
$224
2022
$121
2021
$178
2020
$52
2019
$144
2018
$200
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
CALLIDITAS THERAPEUTICS US INC.
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$101
Otsuka Pharmaceutical Development & Commercialization, Inc.
$97
Travere Therapeutics, Inc.
$95
AstraZeneca Pharmaceuticals LP
$76
Bayer Healthcare Pharmaceuticals Inc.
$71
Fresenius USA Marketing, Inc.
$25
Amgen Inc.
$17
Top 3 companies account for 51.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$263
Otsuka America Pharmaceutical, Inc.
$152
Bayer Healthcare Pharmaceuticals Inc.
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$117
BAXTER HEALTHCARE
$115
CALLIDITAS THERAPEUTICS US INC.
$109
Travere Therapeutics, Inc.
$108
Otsuka Pharmaceutical Development & Commercialization, Inc.
$97
Horizon Therapeutics plc
$78
Vifor Pharma, Inc.
$73
Amgen Inc.
$65
Calliditas Therapeutics US Inc.
$58
Fresenius USA Marketing, Inc.
$56
Bayer HealthCare Pharmaceuticals Inc.
$46
Relypsa, Inc.
$16
GlaxoSmithKline, LLC.
$13
Keryx Biopharmaceuticals, Inc.
$13
Alnylam Pharmaceuticals Inc.
$12
Top 3 companies account for 35.5% of all-time payments
Associated products mentioned in payments ›
Auryxia · BENLYSTA · FARXIGA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · OXLUMO · Parsabiv · Renal - PD · TARPEYO · Velphoro · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nephrologists within 10 mi
54
Per 100K population
21.9
County median income
$107,843
Nearest hospital
ATRIUM MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a clinical cardiology specialist, with above-average Medicare volume (top 15% in OH), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Patel performed 387 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $1,512 from 18 companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other nephrologists in Middletown?
Dr. Patel's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Middletown
Browse nephrologists in Middletown ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in OH
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in OH
Which OH nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology